A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)

NCT00049777 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Drotrecogin Alfa (Activated)
DRUG: Unfractionated heparin
DRUG: Low molecular weight heparin

Sponsor

Eli Lilly and Company